venclextahcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * SITEMAP: | ||
Meta Tags
| Title | VENCLEXTA® (venetoclax tablets) AML & CLL/SLL Treatment HCP |
| Description | Explore phase 3 data for CLL & Select a VENCLEXTA® indication. VENCLEXTA is an oral therapy for select AML, CLL and SLL patients. See full safety and Prescribing Information for more |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 159.180.132.176 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
venclextahcp.com Valuation
|
US$18,451,254
Last updated: 2023-04-30 17:44:06
venclextahcp.com has Semrush global rank of 573,636. venclextahcp.com has an estimated worth of US$ 18,451,254, based on its estimated Ads revenue. venclextahcp.com receives approximately 2,128,991 unique visitors each day. Its web server is located in United States, with IP address 159.180.132.176. According to SiteAdvisor, venclextahcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$18,451,254 |
| Daily Ads Revenue | US$17,032 |
| Monthly Ads Revenue | US$510,958 |
| Yearly Ads Revenue | US$6,131,494 |
| Daily Unique Visitors | 141,933 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| venclextahcp.com. | A | 3599 | IP: 159.180.132.176 |
| venclextahcp.com. | NS | 3600 | NS Record: abvegdmzns1.abbvie.com. |
| venclextahcp.com. | NS | 3600 | NS Record: abvludmzns1.abbvie.com. |
| venclextahcp.com. | NS | 3600 | NS Record: abvsgdmzns1.abbvie.com. |
HtmlToTextCheckTime:2023-04-30 17:44:06
| For Patients and Caregivers MENU View by Patient Type Contact a Representative Contact a Representative Register for Updates Register for Updates Prescribing Information Prescribing Information Safety Information Safety Acute Myeloid Leukemia (AML) Chronic Lymphocytic Leukemia (CLL) View by Patient Type Acute Myeloid Leukemia (AML) Chronic Lymphocytic Leukemia (CLL) Contact a Representative Register for Updates Prescribing Information Safety For Patients and Caregivers Explore phase 3 data for CLL & AML View Prescribing Information Choose a patient type: Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) Acute Myeloid Leukemia (AML) Explore phase 3 data for CLL & AML View Prescribing Information Choose a patient type: Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) Acute Myeloid Leukemia (AML) Important Safety Information & Indications Back to Top Indications VENCLEXTA is indicated: For the treatment of adult patients with chronic lymphocytic |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: http://www.venclextahcp.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Server: awselb/2.0 Date: Sat, 23 Oct 2021 11:24:26 GMT Content-Type: text/html Content-Length: 134 Connection: close Location: https://www.venclextahcp.com:443/ HTTP/2 200 date: Sat, 23 Oct 2021 11:24:27 GMT content-type: text/html; charset=UTF-8 content-length: 66953 server: Apache accept-ranges: bytes vary: Accept-Encoding |
venclextahcp.com Whois Information
Domain Name: VENCLEXTAHCP.COM Registry Domain ID: 2042071741_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-06-09T09:19:59Z Creation Date: 2016-07-11T20:05:08Z Registry Expiry Date: 2022-07-11T20:05:08Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: HLRNS1.ROCHE.COM Name Server: NS1.ROCHE.COM Name Server: NS2.ROCHE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T22:19:16Z <<< |